Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2009, p. 3765-3768, Vol. 47, No. 11
0095-1137/09/$08.00+0 doi:10.1128/JCM.00934-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Richard Goering,2
Marc Stegger,1
Jodi A. Lindsay,3
Katherine A. Gould,3
Jason Hinds,3
Marit Sørum,1
Henrik Westh,4,5
Kit Boye,4 and
Robert Skov1*
National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark,1 Department of Microbiology, Saint Joseph Hospital, Creighton University Medical Centre, Omaha, Nebraska,2 Centre for Infection, Division of Cellular & Molecular Medicine, St. George's, University of London, London, United Kingdom,3 Department of Clinical Microbiology, Hvidovre Hospital, Hvidovre, Denmark,4 Faculty of Health, University of Copenhagen, Copenhagen, Denmark5
Received 12 May 2009/ Returned for modification 17 June 2009/ Accepted 8 September 2009
Analysis of methicillin-resistant Staphylococcus aureus (MRSA) characterized as USA300 by pulsed-field gel electrophoresis identified two distinct clones. One was similar to community-associated USA300 MRSA (ST8-IVa, t008, and Panton-Valentine leukocidin positive). The second (ST8-IVa, t024, and PVL negative) had different molecular characteristics and epidemiology, suggesting independent evolution. We recommend spa typing and/or PCR to discriminate between the two clones.
Published ahead of print on 16 September 2009.
Present affiliation: LEO Pharma, Industriparken 55, DK-2750 Ballerup, Denmark.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»